Summary
The biliary excretion of temafloxacin and temafloxacin glucuronide was characterised in this study after administration of a single oral temafloxacin 600mg dose to 8 patients with T-tube drainage of the common bile duct inserted after cholecystectomy or choledochotomy.
High performance liquid Chromatographic analyses of plasma, urine and bile samples collected during the 72h after temafloxacin administration showed that biliary concentrations of unchanged temafloxacin followed a time-course parallel to plasma concentrations but were 5- to 10-fold higher. Biliary temafloxacin peak concentrations ranged from 18.74 to 64.35 mg/L and time to peak concentrations from 0.71 to 10.23h. Mean hepatobiliary clearance of temafloxacin was 3.10 ml/min (0.19 L/h) when calculated for the unchanged drug and 1.43 ml/min (0.09 L/h) when calculated for its biliary excretion as glucuronic acid conjugates. Patients with higher bile production had markedly higher clearance of both temafloxacin and temafloxacin glucuronide. The elimination time-course of the conjugate in bile generally paralleled those of temafloxacin in bile and plasma, although there was a lag in the rate of appearance of the conjugate in bile.
Biliary excretion of unchanged temafloxacin and temafloxacin glucuronide accounted for approximately 2.2 and 1% of the administered dose, respectively. Thus, it appears that hepatobiliary elimination of temafloxacin and its glucuronide acid accounts for only a small fraction of total temafloxacin clearance. Nonetheless, concentrations attained in the bile are far above the minimum inhibitory concentration values of pathogens relevant in biliary tract infections.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergan T. Pharmacokinetics of ciprofloxacin with reference to other fluorinated quinolones. Journal of Chemotherapy 1: 10–17, 1989
Brogard JM, Koechlim C, Westphal JF, Blickle JF, Dorner M, et al. Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation. Drugs in Experimental and Clinical Research 16: 407416, 1990
Documenta Geigy Scientific Tables vol.1: p139, 1981
Edlund C, Lindquist L, Nord CE. Norfloxacin binds to human fecal material. Antimicrobial Agents and Chemotherapy 32: 1869–1874, 1988
Granneman GR. Pharmacokinetics of temafloxacin after multiple oral administration. Clinical Pharmacokinetics 22 (Suppl. 1): 14–23, 1992
Granneman GR, Carpentier P, Morrison PJ, Pernet AG. Pharmacokinetics of temafloxacin in humans after single oral doses. Antimicrobial Agents and Chemotherapy 35: 436–441, 1991a
Granneman GR, Carpentier P, Morrison PJ, Pernet AG. Pharmacokinetics of temafloxacin in humans after multiple oral doses. Antimicrobial Agents and Chemotherapy, in press, 1991b
Granneman GR, Braeckman R, Carpentier P, Pernet AG. Pharmacokinetics of temafloxacin after single intravenous 100, 200, 400, 600 and 800mg doses. Abstract 383. 17th International Congress of Chemotherapy, Berlin, 1991c
Granneman GR, Mahr G, Locke C, Nickel P, Kirch W, et al. Pharmacokinetics of temafloxacin in patients with liver impairment. Clinical Pharmacokinetics 22 (Suppl. 1): 24–32, 1992b
Granneman GR, Stephan U, Birner B, Sörgel F, Mukherjee D. Effect of antacid medication on the pharmacokinetics of temafloxacin. Clinical Pharmacokinetics 22 (Suppl. 1): 83–89, 1992a
Kinzig M, Seelmann R, Mahr G, Sorgel F, Naber KG, Weidekamm E, Stockel K. 1991. Significant gastrointestinal secretion of fleroxacin in man. 17th International Congress of Chemotherapy (Abstract 388)
Plaa GL. The Non-Renal Excretion of Drugs. In “La Du, B.N., H.G. Mandel, E.L. Way (eds.). Fundamentals of Drug Metabolism and Drug Disposition.” Baltimore 1971, p. 131 ff., 1971
Rohwedder R, Bergan T, Thorsteinsson SB, Scholl H. Transintestinal elimination of ciprofloxacin. Chemotherapy 36: 77–84, 1990
SAS Institute Inc. SAS/STAT user’s guide. Release 6.03 edition, p. 1028, SAS Institute Inc., Cary, N.C., 1988
Sörgel F, Naber KG, Jaehde U, Reiter A, Seelmann R, et al. The use of activated charcoal to estimate the gastrointestinal transit of ciprofloxacin in man. ‘Ciprofloxacin: major advances in intravenous and oral quinolone therapy’ Symposium, Naples, Apr 28–29, 1989
Sörgel F, Naber KG, Mahr G, Muth P, Kinzig M, Weigel D, Honneknovel K, Dinkeldein U. Transintestinal elimination of ofloxacin in man. 17th International Congress of Chemotherapy (Abstract 389), 1991
Sörgel F, Granneman GR, Stephan U, Locke C. Effect of cimetidine on the pharmacokinetics of temafloxacin. Clinical Pharmacokinetics 22 (Suppl. 1): 75–82, 1992
Author information
Authors and Affiliations
Additional information
Data contained in this article form part of the PhD thesis of Gerhard Mahr, which is to be submitted to the University of Bonn.
Rights and permissions
About this article
Cite this article
Sörgel, F., Granneman, G.R., Mahr, G. et al. Hepatobiliary Elimination of Temafloxacin. Clin. Pharmacokinet. 22 (Suppl 1), 33–42 (1992). https://doi.org/10.2165/00003088-199200221-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199200221-00007